TY  - JOUR

T1  - A randomized open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC : the European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR trial

JO  - Journal of Thoracic Oncology

UR  - http://eprints.whiterose.ac.uk/163844/

PY  - 2020/06/18

AU  - Peters S

AU  - Danson S

AU  - Hasan B

AU  - Dafni U

AU  - Reinmuth N

AU  - Majem M

AU  - Tournoy KG

AU  - Mark MT

AU  - Pless M

AU  - Cobo M

AU  - Rodriguez-Abreu D et al

ED  - 

DO  - DOI: 10.1016/j.jtho.2020.06.011

PB  - Elsevier

Y2  - 2025/01/03

ER  -